◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Axa Equitable Holdings Inc (EQH) EBITDA 2014–TTM

Name: Axa Equitable Holdings Inc (EQH) ebitda history 2014-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Axa Equitable Holdings Inc annual ebitda for fiscal 2025 was -$97 million, compared with $3.2 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

EQH Annual EBITDA

EBITDA (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31
EBITDA	—	($97M)	$3.2B	$2.2B	$3.8B	$3.4B	$864M	($1.2B)	$3.0B	$1.9B	$3.0B	$586M	$3.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EQH Quarterly EBITDA

EBITDA (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
EBITDA	—	$1.2B	$611M	($1.1B)	($82M)	$442M	$1.5B	$256M	$936M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EBITDA at Comparable Companies

PS EBITDA — Pershing Square Inc.
TPG EBITDA — TPG Inc
CRBG EBITDA — Corebridge Financial Inc.
OWL EBITDA — Blue Owl Capital Inc
CG EBITDA — Carlyle Group Inc
ARCC EBITDA — Ares Capital Corporation

More EQH metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All EQH financial statements → Interactive EQH charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.